Esbriet 267 MG tablet 270S
Ended Awarded Last action
- Contract number
- SPE2DR26FDB0P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,449
Award facts
- Contract value 100% obligated
- $10,449.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp (parent company Cencora, Inc.) on January 22, 2026, for the supply of Esbriet 267 mg tablets in a quantity of 270 units, with a contract ceiling value of $10,449.43. This is a firm fixed-price delivery order with an ultimate completion date of February 12, 2026. The award utilized no set-aside designation, indicating the contract was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. Esbriet (pirfenidone) is an antifibrotic agent primarily used in the treatment of idiopathic pulmonary fibrosis, reflecting the Defense Health Agency's medical supply requirements for specialized therapeutics across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FDB0P?
SPE2DR26FDB0P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FDB0P worth?
The government has obligated $10,449 on SPE2DR26FDB0P.
Is contract SPE2DR26FDB0P an order under another contract?
Yes. SPE2DR26FDB0P is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FDB0P competed?
The extent of competition for SPE2DR26FDB0P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award